Skip to content

PACIFIC HEALTH CARE ORGANIZATION, INC.: 10-Q filed 2024-08-07

What PACIFIC HEALTH CARE ORGANIZATION, INC. reported in its quarterly report filed 2024-08-07 (fiscal Q2 2024): 36 published measures, 105 facts as tagged in accession 0001185185-24-000764.

This filing

Form
10-Q (quarterly report)
Filed
2024-08-07
Fiscal period
fiscal Q2 2024
Accession
0001185185-24-000764 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All PACIFIC HEALTH CARE ORGANIZATION, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2024-06-3011,942,598USD
At 2023-12-3111,823,890USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2024-06-30726,020USD
At 2023-12-311,020,271USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2024-06-3011,216,578USD
At 2024-03-3111,001,022USD
At 2023-12-3110,803,619USD
At 2023-06-3010,343,227USD
At 2023-03-3111,448,400USD
At 2022-12-3111,317,291USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2024-06-302,619,437USD
At 2023-12-312,565,992USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2024-04-01 to 2024-06-30215,556USD91
2024-01-01 to 2024-06-30412,959USD182
2024-01-01 to 2024-03-31197,403USD91
2023-04-01 to 2023-06-30176,427USD91
2023-01-01 to 2023-06-30307,536USD181
2023-01-01 to 2023-03-31131,109USD90

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2024-01-01 to 2024-06-30249,563USD182
2023-01-01 to 2023-06-30266,778USD181

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2024-01-01 to 2024-06-305,779USD182
2023-01-01 to 2023-06-301,473USD181

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2024-04-01 to 2024-06-301,569,954USD91
2024-01-01 to 2024-06-302,996,664USD182
2023-04-01 to 2023-06-301,324,053USD91
2023-01-01 to 2023-06-302,665,590USD181

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2024-01-01 to 2024-06-30-14,155USD182
2023-01-01 to 2023-06-30-1,110,984USD181

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2024-01-01 to 2024-06-30-181,963USD182
2023-01-01 to 2023-06-301,103,981USD181

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2024-06-3010,787,705USD
At 2023-12-3110,374,746USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2024-04-01 to 2024-06-3012,800,000shares91
2024-01-01 to 2024-06-3012,800,000shares182
2023-04-01 to 2023-06-3012,800,000shares91
2023-01-01 to 2023-06-3012,800,000shares181

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2024-04-01 to 2024-06-3012,816,000shares91
2024-01-01 to 2024-06-3012,816,000shares182
2023-04-01 to 2023-06-3012,816,000shares91
2023-01-01 to 2023-06-3012,816,000shares181

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2024-04-01 to 2024-06-300.02USD/shares91
2024-01-01 to 2024-06-300.03USD/shares182
2023-04-01 to 2023-06-300.01USD/shares91
2023-01-01 to 2023-06-300.02USD/shares181

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2024-04-01 to 2024-06-300.02USD/shares91
2024-01-01 to 2024-06-300.03USD/shares182
2023-04-01 to 2023-06-300.01USD/shares91
2023-01-01 to 2023-06-300.02USD/shares181

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2024-04-01 to 2024-06-3083,443USD91
2024-01-01 to 2024-06-30160,478USD182
2023-04-01 to 2023-06-3068,849USD91
2023-01-01 to 2023-06-30120,012USD181

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2024-06-3064,632USD
At 2023-12-3177,394USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2024-04-01 to 2024-06-30191,995USD91
2024-01-01 to 2024-06-30367,188USD182
2023-04-01 to 2023-06-30145,118USD91
2023-01-01 to 2023-06-30227,574USD181

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2024-06-3011,870,856USD
At 2023-12-3111,682,897USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2024-06-30726,020USD
At 2023-12-311,008,301USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2024-06-30163,133USD
At 2023-12-31159,789USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2024-06-30941,313USD
At 2023-12-311,020,580USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2024-04-01 to 2024-06-301,377,959USD91
2024-01-01 to 2024-06-302,629,476USD182
2023-04-01 to 2023-06-301,178,935USD91
2023-01-01 to 2023-06-302,438,016USD181

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2024-06-3012,800,000shares
At 2023-12-3112,800,000shares
At 2023-06-0512,800,000shares

Cash including restricted cash

Cash, cash equivalents and restricted cash as reported in the cash flow reconciliation. Restricted amounts are not freely available, so this is not the same as unrestricted cash.

PeriodValueUnitDays
At 2024-06-302,619,437USD
At 2023-12-312,565,992USD
At 2023-06-302,296,207USD
At 2022-12-312,036,432USD

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2024-06-30416,057USD
At 2023-12-31416,057USD

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

PeriodValueUnitDays
At 2024-06-300USD
At 2023-12-3156,489USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2024-06-30254,450USD
At 2023-12-31277,403USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2024-06-30189,818USD
At 2023-12-31200,009USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2024-06-307,110USD
At 2023-12-317,110USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2024-06-30424,318USD
At 2023-12-31367,609USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2024-04-01 to 2024-06-30298,999USD91
2024-01-01 to 2024-06-30573,437USD182
2023-04-01 to 2023-06-30245,276USD91
2023-01-01 to 2023-06-30427,548USD181

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2024-04-01 to 2024-06-30212,913USD91
2024-01-01 to 2024-06-30348,748USD182
2023-04-01 to 2023-06-3087,919USD91
2023-01-01 to 2023-06-30221,675USD181

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2024-04-01 to 2024-06-309,114USD91
2024-01-01 to 2024-06-3018,541USD182
2023-04-01 to 2023-06-309,337USD91
2023-01-01 to 2023-06-3018,716USD181

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2024-01-01 to 2024-06-30-99,137USD182
2023-01-01 to 2023-06-30-70,406USD181

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2024-01-01 to 2024-06-303,344USD182
2023-01-01 to 2023-06-30-182,754USD181

Inspect the source

Entity
PACIFIC HEALTH CARE ORGANIZATION, INC. / CIK 0001138476
Captured
2026-09-20T07:41:43.895Z
SEC response SHA-256
c346f20a25e39115a2e329ae39afd13c2b9308b9c9ca6ca7361c4c6307a72c92

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001138476.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))